Nasdaq gains over 300 points; Chicago PMI falls in June
U.S. stocks rose, led by the Nasdaq's 1.31% gain, while the Chicago PMI fell to 56.7 in June. Tech shares surged, but real estate lagged. Notable movers included Creative Medical Technology Holdings (+416%) and Vistagen Therapeutics (-71%). Commodities were mixed, and global markets showed varied performance.

*this image is generated using AI for illustrative purposes only.
U.S. stocks traded higher midway through trading on Tuesday, with the Nasdaq Composite gaining over 300 points. The Dow traded up 0.28% to 52,327.93, while the Nasdaq rose 1.31% to 26,157.23. The S&P 500 also gained, rising 0.67% to 7,490.49. The rally was driven by a 1.6% jump in information technology shares, while real estate stocks fell by 2.1%.
The Chicago Business Barometer declined to 56.7 in June, down from a reading of 62.7 in the prior month. U.S. job openings rose by 9,000 to 7.594 million in May, compared to market estimates of 7.30 million. The S&P CoreLogic Case-Shiller home price index rose 1.1% year-over-year in April, topping market estimates, while the FHFA house price index fell 0.1% in April.
Market Movers
Several stocks saw significant movement following corporate announcements. Creative Medical Technology Holdings Inc shares shot up 416% to $4.18 after the company filed a Form RW, stating it does not plan to consummate the offering of its securities. 707 Cayman Holdings Ltd shares surged 240% to $3.67 after naming Robin Hoksnes Karlsen as an executive director. Abivax SA shares gained 38% to $132.30 after announcing topline results from ABTECT Maintenance Part 2, with BTIG maintaining a Buy rating and raising its price target to $175.
On the downside, Vistagen Therapeutics Inc shares dropped 71% to $0.22 after announcing topline results from the PALISADE-4 Phase 3 trial, where fasedienol did not achieve its primary endpoint. Sable Offshore Corp shares fell 45% to $3.84 after announcing a $400 million offering. Unicycive Therapeutics Inc shares dropped 45% to $4.21 after receiving a Complete Response Letter from the FDA regarding its New Drug Application for oxylanthanum carbonate.
Commodities and Global Markets
In commodities, oil traded down 1.3% to $69.82, while gold traded up 0.1% at $4,043.30. Silver rose 1.8 to $59.690, and copper gained 1.3% to $6.2445.
European shares were higher, with the STOXX 600 gaining 0.9%. Spain’s IBEX 35 Index rose 0.2%, London’s FTSE 100 gained 0.6%, Germany’s DAX rose 1.2%, and France’s CAC 40 added 0.1%. Asian markets closed mixed, with Japan’s Nikkei 225 gaining 0.86%, Hong Kong’s Hang Seng Index falling 0.63%, China’s Shanghai Composite rising 0.50%, and India’s BSE Sensex dropping 0.33%.
| Index | Value | Change |
|---|---|---|
| Dow | 52,327.93 | +0.28% |
| Nasdaq | 26,157.23 | +1.31% |
| S&P 500 | 7,490.49 | +0.67% |
| STOXX 600 | - | +0.9% |
| Nikkei 225 | - | +0.86% |
Will the surge in information technology shares sustain given the recent pullback in real estate stocks?
How will the unexpected rise in U.S. job openings influence the Federal Reserve's upcoming interest rate decisions?
What impact will the divergent home price index readings have on the housing market outlook for the remainder of the year?






























